Physician profile
Debra Jih
NPI 1790722981
$1,728.94
in general payments reported to CMS, 2019-2025
16 companies · $29.76 in 2025
The $29.76 reported for 2025 was less than what a typical Dermatopathology (Dermatology) provider received nationally (typical 2025 total: $251).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $16.30 · 2021: $196 · 2022: $551 · 2023: $555 · 2024: $84.69 · 2025: $29.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $564.28 | 2019-2024 | |
| Biofrontera INC. | $156.31 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Incyte Corporation | $152.59 | 2021-2024 | Opzelura |
| Verrica Pharmaceuticals INC. | $151.88 | 2023 | Ycanth |
| Janssen Biotech, INC. | $134.24 | 2021-2023 | Tremfya |
| Lilly USA, LLC | $90.91 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $89.43 | 2019-2023 | Dupixent |
| Pfizer INC. | $76.11 | 2019-2023 | |
| Ucb, INC. | $71.49 | 2019-2024 | Bimzelx |
| Leo Pharma INC. | $65.19 | 2022 | |
| Sun Pharmaceutical Industries INC. | $51.86 | 2021-2022 | |
| Amgen INC. | $40.18 | 2022-2025 | Otezla |
| Dusa Pharmaceuticals, INC. | $33.63 | 2019 | |
| Aclaris Therapeutics, INC. | $21.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.12 | 2025 | Sotyktu |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Jih listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.